Last updated on December 2018

GRAVITAS-119: A Single-Arm, Open-Label, Phase 1 Study of Itacitinib in Combination With Calcineurin Inhibitor-Based Interventions for the Prophylaxis of Graft-Versus-Host Disease


Brief description of study

The purpose of this study is to assess the impact on hematologic parameters when itacitinib is added to calcineurin inhibitor (CNI)-based graft-versus-host disease (GVHD) prophylaxis treatment.

Clinical Study Identifier: TX201201

Find a site near you

Start Over

University of Maryland Medical Center

Located in: Baltimore, MD USA
6.25miles
  Connect »